How to manage sodium-glucose cotransporter-2 inhibitors in the critically ill patient?

Intensive Care Med. 2024 Dec 2. doi: 10.1007/s00134-024-07704-0. Online ahead of print.

Authors

Bruno Garcia¹, Marlies Ostermann², Matthieu Legrand³

Affiliations

¹ Department of Intensive Care, Centre Hospitalier Universitaire de Lille, Lille, France.
² Department of Intensive Care, King's College London, Guy's & St Thomas' Hospital, London, UK.
³ Division of Critical Care Medicine, Department of Anesthesia and Peri-Operative Care, University of California San Francisco, San Francisco, USA. matthieu.legrand@ucsf.edu.

PMID: 39621048
DOI: 10.1007/s00134-024-07704-0

No abstract available

Publication types

Editorial